bluuebunny/crossref_metadata_2025 huggingface dataset:
Supplementary Data 3A from miR-122-5p Expression and Secretion in Melanoma Cells Is Amplified by the LPAR3 SH3–Binding Domain to Regulate Wnt1
Authors: Byrnes Charnel C. , Jia Wei , Alshamrani Ali A. , Kuppa Sudeepti S. , Murph Mandi M.
Published: April 2023

Supplementary Figure 3. Microfluidics visualization of nanoparticles from LPAR3. The movies illustrate the difference between the smaller/almost indiscernible white dots, which are exosome nanoparticles, secreted by cells expressing LPAR3-wt versus the larger particles, likely multi-vesicular bodies, but not exosomes.
Table S1 from Tumor Progression Is Mediated by Thymosin-β4 through a TGFβ/MRTF Signaling Axis
Authors: Morita Tsuyoshi , Hayashi Ken'ichiro
Published: April 2023

Table S1 shows list of PCR primers and siRNAs used in this study.
Figure S4 from Tumor Progression Is Mediated by Thymosin-β4 through a TGFβ/MRTF Signaling Axis
Authors: Morita Tsuyoshi , Hayashi Ken'ichiro
Published: April 2023

Figure S4 shows expression profile of SERPINE1 gene in human cancers.
Supplementary Table S2 from Global Increase of p16INK4a in APC-Deficient Mouse Liver Drives Clonal Growth of p16INK4a-Negative Tumors
Authors: Ueberham Elke , Glöckner Pia , Göhler Claudia , Straub Beate K. , Teupser Daniel , Schönig Kai , Braeuning Albert , Höhn Anne Kathrin , Jerchow Boris , Birchmeier Walter , Gaunitz Frank , Arendt Thomas , Sansom Owen , Gebhardt Rolf , Ueberham Uwe
Published: April 2023

List of primary antibodies.
Supplementary Figure S4 from Global Increase of p16INK4a in APC-Deficient Mouse Liver Drives Clonal Growth of p16INK4a-Negative Tumors
Authors: Ueberham Elke , Glöckner Pia , Göhler Claudia , Straub Beate K. , Teupser Daniel , Schönig Kai , Braeuning Albert , Höhn Anne Kathrin , Jerchow Boris , Birchmeier Walter , Gaunitz Frank , Arendt Thomas , Sansom Owen , Gebhardt Rolf , Ueberham Uwe
Published: April 2023

Separate depiction of immunohistochemical staining of p16INK4a in situ.
Supplementary Figure S1 from Global Increase of p16INK4a in APC-Deficient Mouse Liver Drives Clonal Growth of p16INK4a-Negative Tumors
Authors: Ueberham Elke , Glöckner Pia , Göhler Claudia , Straub Beate K. , Teupser Daniel , Schönig Kai , Braeuning Albert , Höhn Anne Kathrin , Jerchow Boris , Birchmeier Walter , Gaunitz Frank , Arendt Thomas , Sansom Owen , Gebhardt Rolf , Ueberham Uwe
Published: April 2023

Breeding Schema.
Supplemental Data from Integrated Genomic Comparison of Mouse Models Reveals Their Clinical Resemblance to Human Liver Cancer
Authors: Yim Sun Young , Shim Jae-Jun , Shin Ji-Hyun , Jeong Yun Seong , Kang Sang-Hee , Kim Sang-Bae , Eun Young Gyu , Lee Dong Jin , Conner Elizabeth A. , Factor Valentina M. , Moore David D. , Johnson Randy L. , Thorgeirsson Snorri S. , Lee Ju-Seog
Published: April 2023

S1. Correlation of prognostic probability and risk scores for mouse HCCs. S2. Glycolytic gene expression signature in mouse liver. S3. Glycolytic expression signature in mouse HCC tumors from 9 models. S4. Correlation of hepatic stem cell probability with SOH probability. S5. Expression of hepatic stem cell markers in 9 mouse models. S6. Expression of Krt-7 in Sav1 KO liver issues. S7. Expression of downstream target genes in mouse tumors. S8. Expression of Pdcd1 and Cd274 and their correlation with IFNG6 score in mouse HCCs in nine models. S9. Regulation of Cd276 by Yap1.
Supplementary Figure 1 from Adaptation to HIF1α Deletion in Hypoxic Cancer Cells by Upregulation of GLUT14 and Creatine Metabolism
Authors: Valli Alessandro , Morotti Matteo , Zois Christos E. , Albers Patrick K. , Soga Tomoyoshi , Feldinger Katharina , Fischer Roman , Frejno Martin , McIntyre Alan , Bridges Esther , Haider Syed , Buffa Francesca M. , Baban Dilair , Rodriguez Miguel , Yanes Oscar , Whittington Hannah J. , Lake Hannah A. , Zervou Sevasti , Lygate Craig A. , Kessler Benedikt M. , Harris Adrian L.
Published: April 2023

S1. Blocking O-GlcNAcylation in vivo by inducing shOGT or alloxan treatment qualitatively reduces EZH2 immunoreactivity after irradiation.
Supplementary data from Histone H3.3K27M Represses p16 to Accelerate Gliomagenesis in a Murine Model of DIPG
Authors: Cordero Francisco J. , Huang Zhiqing , Grenier Carole , He Xingyao , Hu Guo , McLendon Roger E. , Murphy Susan K. , Hashizume Rintaro , Becher Oren J.
Published: April 2023

lists of antibodies and primer information used in the manuscript.
Table S5 from T-Cell Deletion of MyD88 Connects IL17 and IκBζ to RAS Oncogenesis
Authors: Cataisson Christophe , Salcedo Rosalba , Michalowski Aleksandra M. , Klosterman Mary , Naik Shruti , Li Luowei , Pan Michelle J. , Sweet Amalia , Chen Jin-Qiu , Kostecka Laurie G. , Karwan Megan , Smith Loretta , Dai Ren-Ming , Stewart C. Andrew , Lyakh Lyudmila , Hsieh Wang-Ting , Khan Asra , Yang Howard , Lee Maxwell , Trinchieri Giorgio , Yuspa Stuart H.
Published: April 2023

Primers used for mouse colonies genotyping.
Table S3 from T-Cell Deletion of MyD88 Connects IL17 and IκBζ to RAS Oncogenesis
Authors: Cataisson Christophe , Salcedo Rosalba , Michalowski Aleksandra M. , Klosterman Mary , Naik Shruti , Li Luowei , Pan Michelle J. , Sweet Amalia , Chen Jin-Qiu , Kostecka Laurie G. , Karwan Megan , Smith Loretta , Dai Ren-Ming , Stewart C. Andrew , Lyakh Lyudmila , Hsieh Wang-Ting , Khan Asra , Yang Howard , Lee Maxwell , Trinchieri Giorgio , Yuspa Stuart H.
Published: April 2023

Supplemental table 3: List of genes from RNA profiling, the expression of which is significantly affected (by at least 1.5-fold change and FDR <5%) by IkBz deficiency in RAS-keratinocytes.
PDGF signaling cooperates with H3.3K27M to increase tumor malignancy from Histone H3.3K27M Represses p16 to Accelerate Gliomagenesis in a Murine Model of DIPG
Authors: Cordero Francisco J. , Huang Zhiqing , Grenier Carole , He Xingyao , Hu Guo , McLendon Roger E. , Murphy Susan K. , Hashizume Rintaro , Becher Oren J.
Published: April 2023

A. Analysis of tumor volume of PDGF driven, p53 WT models with expression of H3.3K27M (n= 6), H3.3WT (n= 6), or empty vector (n= 7) shows trend for larger tumors with mutation compared to H3.3WT (p= 0.25) or empty vector (p= 0.28) controls. B. Kaplan-Meier survival curve of murine tumors driven by co-injection of nestin tv-a; p53 floxed mice with RCAS-PDGFB; RCAS-Cre; and either RCAS-H3.3K27M-GFP (n=12) or RCAS-H3.3WT-GFP (n= 18). C. In vivo proliferation quantification of H3.3K27M or H3.3WT expressing tumors driven by PDGFB overexpression and p53 knockout using pH3 (H3.3K27M n= 5, H3.3WT n=4) or D. EdU incorporation IF quantification (n=3 each) E. Histone extraction followed by western blot using total H3 antibody comparing murine tumor cells infected with empty vector, H3.3WT, or H3.3K27M to determine the amount of H3 overexpression.
H3.3K27M affects gene expression of PRC2 target genes and focally represses p16 expression from Histone H3.3K27M Represses p16 to Accelerate Gliomagenesis in a Murine Model of DIPG
Authors: Cordero Francisco J. , Huang Zhiqing , Grenier Carole , He Xingyao , Hu Guo , McLendon Roger E. , Murphy Susan K. , Hashizume Rintaro , Becher Oren J.
Published: April 2023

A. Gene set enrichment analysis of differentially upregulated genes from RNA-Seq of high grade tumor model with or without H3.3K27M-HA expression shows high association with known PRC2-regulated H3K27me3 target genes in mouse embryonic, and neuronal progenitor cells (1). B. GSEA comparing genes losing H3K27me3 (UPS) and gaining H3K27me3 (DOWN) from Chan et al to our mouse tumor RNA-Seq. C. qPCR analysis of both p16 and p19 alternate transcripts from ex-vivo infected neuronal progenitor cells isolated from neonatal Nestin-tv-a pups and infected with either H3.3K27M-HA, H3.3WT-HA, or empty vector 2 weeks prior to collection.
Figure S4 from PPARδ Reprograms Glutamine Metabolism in Sorafenib-Resistant HCC
Authors: Kim Mi-Jin , Choi Yeon-Kyung , Park Soo Young , Jang Se Young , Lee Jung Yi , Ham Hye Jin , Kim Byung-Gyu , Jeon Hui-Jeon , Kim Ji-Hyun , Kim Jung-Guk , Lee In-Kyu , Park Keun-Gyu
Published: April 2023

Figure S4 shows relative abundance of indicated protein levels and effect of PPARÎ' inhibitor on growth in sorafenib-sensitive and -resistant HCC cells.
Figure S3 from PPARδ Reprograms Glutamine Metabolism in Sorafenib-Resistant HCC
Authors: Kim Mi-Jin , Choi Yeon-Kyung , Park Soo Young , Jang Se Young , Lee Jung Yi , Ham Hye Jin , Kim Byung-Gyu , Jeon Hui-Jeon , Kim Ji-Hyun , Kim Jung-Guk , Lee In-Kyu , Park Keun-Gyu
Published: April 2023

Figure S3 shows relative amount of intracellular glutamine level and abundance of indicated protein levels in sorafenib-sensitive and -resistant HCC cells.
Figure S1 from PPARδ Reprograms Glutamine Metabolism in Sorafenib-Resistant HCC
Authors: Kim Mi-Jin , Choi Yeon-Kyung , Park Soo Young , Jang Se Young , Lee Jung Yi , Ham Hye Jin , Kim Byung-Gyu , Jeon Hui-Jeon , Kim Ji-Hyun , Kim Jung-Guk , Lee In-Kyu , Park Keun-Gyu
Published: April 2023

Figure S1 shows relative protein abudance of indicated protein levels in sorafenib-sensitive HCC (Huh7 and SK-Hep1) and -resistant HCC (Huh7-R and SK-H-R) cells.
Revised supplementary Table 4 from Genome-Wide Analysis Identifies MEN1 and MAX Mutations and a Neuroendocrine-Like Molecular Heterogeneity in Quadruple WT GIST
Authors: Pantaleo Maria A. , Urbini Milena , Indio Valentina , Ravegnini Gloria , Nannini Margherita , De Luca Matilde , Tarantino Giuseppe , Angelini Sabrina , Gronchi Alessandro , Vincenzi Bruno , Grignani Giovanni , Colombo Chiara , Fumagalli Elena , Gatto Lidia , Saponara Maristella , Ianni Manuela , Paterini Paola , Santini Donatella , Pirini M. Giulia , Ceccarelli Claudio , Altimari Annalisa , Gruppioni Elisa , Renne Salvatore L. , Collini Paola , Stacchiotti Silvia , Brandi Giovanni , Casali Paolo G. , Pinna Antonio D. , Astolfi Annalisa , Biasco Guido
Published: April 2023

High-confidence somatic SNV and inDel
Revised supplementary Table 3 from Genome-Wide Analysis Identifies MEN1 and MAX Mutations and a Neuroendocrine-Like Molecular Heterogeneity in Quadruple WT GIST
Authors: Pantaleo Maria A. , Urbini Milena , Indio Valentina , Ravegnini Gloria , Nannini Margherita , De Luca Matilde , Tarantino Giuseppe , Angelini Sabrina , Gronchi Alessandro , Vincenzi Bruno , Grignani Giovanni , Colombo Chiara , Fumagalli Elena , Gatto Lidia , Saponara Maristella , Ianni Manuela , Paterini Paola , Santini Donatella , Pirini M. Giulia , Ceccarelli Claudio , Altimari Annalisa , Gruppioni Elisa , Renne Salvatore L. , Collini Paola , Stacchiotti Silvia , Brandi Giovanni , Casali Paolo G. , Pinna Antonio D. , Astolfi Annalisa , Biasco Guido
Published: April 2023

Copy number alterations on chromosome 1, 14 and 22 with the related genes of Cancer Gene Census
Supplementary table 3 from Blockade of AP-1 Potentiates Endocrine Therapy and Overcomes Resistance
Authors: Malorni Luca , Giuliano Mario , Migliaccio Ilenia , Wang Tao , Creighton Chad J. , Lupien Mathieu , Fu Xiaoyong , Hilsenbeck Susan G. , Healy Nuala , De Angelis Carmine , Mazumdar Abhijit , Trivedi Meghana V. , Massarweh Suleiman , Gutierrez Carolina , De Placido Sabino , Jeselsohn Rinath , Brown Myles , Brown Powel H. , Osborne C. Kent , Schiff Rachel
Published: April 2023

Time to response, time to complete response, and rate of complete response to endocrine treatment +/- Dox in xenografts of MCF7 Tet-off Vector Control clone 3.
Figure S7 from Molecular Signature and Mechanisms of Hepatitis D Virus–Associated Hepatocellular Carcinoma
Authors: Diaz Giacomo , Engle Ronald E. , Tice Ashley , Melis Marta , Montenegro Stephanie , Rodriguez-Canales Jaime , Hanson Jeffrey , Emmert-Buck Michael R. , Bock Kevin W. , Moore Ian N. , Zamboni Fausto , Govindarajan Sugantha , Kleiner David E. , Farci Patrizia
Published: April 2023

HBV DNA levels in tumorous and non-tumorous tissues of individual patients with HBV-associated HCC.
Supplementary table 1 from Blockade of AP-1 Potentiates Endocrine Therapy and Overcomes Resistance
Authors: Malorni Luca , Giuliano Mario , Migliaccio Ilenia , Wang Tao , Creighton Chad J. , Lupien Mathieu , Fu Xiaoyong , Hilsenbeck Susan G. , Healy Nuala , De Angelis Carmine , Mazumdar Abhijit , Trivedi Meghana V. , Massarweh Suleiman , Gutierrez Carolina , De Placido Sabino , Jeselsohn Rinath , Brown Myles , Brown Powel H. , Osborne C. Kent , Schiff Rachel
Published: April 2023

Supplementary Table 1: Genes up-regulated in Tam-R and putatively associated with EGF-induced ER binding sites.
Figure S6 from Molecular Signature and Mechanisms of Hepatitis D Virus–Associated Hepatocellular Carcinoma
Authors: Diaz Giacomo , Engle Ronald E. , Tice Ashley , Melis Marta , Montenegro Stephanie , Rodriguez-Canales Jaime , Hanson Jeffrey , Emmert-Buck Michael R. , Bock Kevin W. , Moore Ian N. , Zamboni Fausto , Govindarajan Sugantha , Kleiner David E. , Farci Patrizia
Published: April 2023

Synopsis of the 20 top-scored pathways associated with WLT-unique genes identified in the three tumors.
Supplementary Figure 2 from Chromosome 20q Amplification Defines a Subtype of Microsatellite Stable, Left-Sided Colon Cancers with Wild-type RAS/RAF and Better Overall Survival
Authors: Ptashkin Ryan N. , Pagan Carlos , Yaeger Rona , Middha Sumit , Shia Jinru , O'Rourke Kevin P. , Berger Michael F. , Wang Lu , Cimera Robert , Wang Jiajing , Klimstra David S. , Saltz Leonard , Ladanyi Marc , Zehir Ahmet , Hechtman Jaclyn F.
Published: April 2023

(a) Barplot of GISTIC2.0 chromosome 20q gene level copy number calls in TCGA COADREAD data and (b) chromosome 20q genes covered by MSK-IMPACT. (c) Interquartile range (IGR) of gene level RNASeq expression z-score by copy number group from 2a. (d) MSK-IMPACT and TCGA tumor purity estimates.
Supplementary Figure 1 from Chromosome 20q Amplification Defines a Subtype of Microsatellite Stable, Left-Sided Colon Cancers with Wild-type RAS/RAF and Better Overall Survival
Authors: Ptashkin Ryan N. , Pagan Carlos , Yaeger Rona , Middha Sumit , Shia Jinru , O'Rourke Kevin P. , Berger Michael F. , Wang Lu , Cimera Robert , Wang Jiajing , Klimstra David S. , Saltz Leonard , Ladanyi Marc , Zehir Ahmet , Hechtman Jaclyn F.
Published: April 2023

(a) Plot of SCNA in a CRC with 20q amplification as detected by MSK-IMPACT and (b) high resolution SNP analysis on Oncoscan confirmed the results without showing focal amplifications
Supplemental Tables from Chromosome 20q Amplification Defines a Subtype of Microsatellite Stable, Left-Sided Colon Cancers with Wild-type RAS/RAF and Better Overall Survival
Authors: Ptashkin Ryan N. , Pagan Carlos , Yaeger Rona , Middha Sumit , Shia Jinru , O'Rourke Kevin P. , Berger Michael F. , Wang Lu , Cimera Robert , Wang Jiajing , Klimstra David S. , Saltz Leonard , Ladanyi Marc , Zehir Ahmet , Hechtman Jaclyn F.
Published: April 2023

Supplemental Tables
Supplementary Figure Legends and Methods from Intron 1–Mediated Regulation of EGFR Expression in EGFR-Dependent Malignancies Is Mediated by AP-1 and BET Proteins
Authors: Jameson Nathan M. , Ma Jianhui , Benitez Jorge , Izurieta Alejandro , Han Jee Yun , Mendez Robert , Parisian Alison , Furnari Frank
Published: April 2023

Supplementary figure legends, supplementary methods and supplementary references
Text S2 from The Landscape of Isoform Switches in Human Cancers
Authors: Vitting-Seerup Kristoffer , Sandelin Albin
Published: April 2023

Additional information about IsoformSwitchAnalyzeR including justification of cutoffs, accuracy and the derivation of the statistical test implemented in IsoformSwitchAnalyzeR.
Table S5 from The Landscape of Isoform Switches in Human Cancers
Authors: Vitting-Seerup Kristoffer , Sandelin Albin
Published: April 2023

Pan-cancer predictors of patient survival.
Table S4 from The Landscape of Isoform Switches in Human Cancers
Authors: Vitting-Seerup Kristoffer , Sandelin Albin
Published: April 2023

Pan-cancer Isoform Switches with Predicted Consequences.
Table S2 from Discrete Adaptive Responses to MEK Inhibitor in Subpopulations of Triple-Negative Breast Cancer
Authors: Goulet Daniel R. , Foster Joseph P. , Zawistowski Jon S. , Bevill Samantha M. , Noël Mélodie P. , Olivares-Quintero José F. , Sciaky Noah , Singh Darshan , Santos Charlene , Pattenden Samantha G. , Davis Ian J. , Johnson Gary L.
Published: April 2023

WES Coding Mutations
Supplementary figures 1-3 from A Leukocyte Infiltration Score Defined by a Gene Signature Predicts Melanoma Patient Prognosis
Authors: Zhao Yanding , Schaafsma Evelien , Gorlov Ivan P. , Hernando Eva , Thomas Nancy E. , Shen Ronglai , Turk Mary Jo , Berwick Marianne , Amos Christopher I. , Cheng Chao
Published: April 2023

Figure S1. LIS reflects immune cell infiltration in melanoma microenvironment. Figure S2. LIS is associated with clinical factors and provided prognostic value in addition to clinical information in melanoma. Figure S3. LIS is predictive of prognosis and immunotherapy response and correlated with genomic features in melanoma.
Figure S3 from Discrete Adaptive Responses to MEK Inhibitor in Subpopulations of Triple-Negative Breast Cancer
Authors: Goulet Daniel R. , Foster Joseph P. , Zawistowski Jon S. , Bevill Samantha M. , Noël Mélodie P. , Olivares-Quintero José F. , Sciaky Noah , Singh Darshan , Santos Charlene , Pattenden Samantha G. , Davis Ian J. , Johnson Gary L.
Published: April 2023

Unique Enhancer Remodeling and Transcriptional Response Persists Following Chronic Trametinib Treatment.
Figure S2 from Discrete Adaptive Responses to MEK Inhibitor in Subpopulations of Triple-Negative Breast Cancer
Authors: Goulet Daniel R. , Foster Joseph P. , Zawistowski Jon S. , Bevill Samantha M. , Noël Mélodie P. , Olivares-Quintero José F. , Sciaky Noah , Singh Darshan , Santos Charlene , Pattenden Samantha G. , Davis Ian J. , Johnson Gary L.
Published: April 2023

Differential Remodeling of the Enhancer Landscape is Associated with the Transcriptional Response to Trametinib.
Figure S1 from Discrete Adaptive Responses to MEK Inhibitor in Subpopulations of Triple-Negative Breast Cancer
Authors: Goulet Daniel R. , Foster Joseph P. , Zawistowski Jon S. , Bevill Samantha M. , Noël Mélodie P. , Olivares-Quintero José F. , Sciaky Noah , Singh Darshan , Santos Charlene , Pattenden Samantha G. , Davis Ian J. , Johnson Gary L.
Published: April 2023

TNBC Subpopulations Are Genotypically Similar But Epigenetically Distinct.
Figure S4 from CREBBP/EP300 Bromodomain Inhibition Affects the Proliferation of AR-Positive Breast Cancer Cell Lines
Authors: Garcia-Carpizo Veronica , Ruiz-Llorente Sergio , Sarmentero Jacinto , González-Corpas Ana , Barrero Maria J.
Published: April 2023

Effects of treatments on MYC expression. mRNA determined by qPCR and normalized to GAPDH expression (top panel) and protein levels determined by western blot (bottom panel) of MYC after treatment of cells with 2 μM CBP30, 10 μM C646 and 150 nM JQ1 for 48 hours.
Supplemental methods from Digital PCR-Based T-cell Quantification–Assisted Deconvolution of the Microenvironment Reveals that Activated Macrophages Drive Tumor Inflammation in Uveal Melanoma
Authors: de Lange Mark J. , Nell Rogier J. , Lalai Rajshri N. , Versluis Mieke , Jordanova Ekaterina S. , Luyten Gre P.M. , Jager Martine J. , van der Burg Sjoerd H. , Zoutman Willem H. , van Hall Thorbald , van der Velden Pieter A.
Published: April 2023

Description of analysis
Figure S1 from CREBBP/EP300 Bromodomain Inhibition Affects the Proliferation of AR-Positive Breast Cancer Cell Lines
Authors: Garcia-Carpizo Veronica , Ruiz-Llorente Sergio , Sarmentero Jacinto , González-Corpas Ana , Barrero Maria J.
Published: April 2023

Statistical analysis of growth competition assays (a) ANOVA diamond plots showing the adjusted % of inhibition at day 12 for gRNAs grouped into the indicated categories and considering three independent experiments. (b) Tukey-Kramer statistical test results of data shown in a. p-values<0.05 are highlighted in bold and considered significantly different from other categories.
Supplemental Table 2 from Elevated V–ATPase Activity Following PTEN Loss Is Required for Enhanced Oncogenic Signaling in Breast Cancer
Authors: Mohammad Amro H. , Kim Sung-Hoon , Bertos Nicholas , El-Assaad Wissal , Nandi Ipshita , Smith Harvey , Yang Jieyi , Chen Owen J. , Gamache Isabelle , Rao Trisha , Gagnon Bruno , Gruosso Tina , Tremblay Michel L. , Sonenberg Nahum , Guiot Marie-Christine , Muller William , Park Morag , Teodoro Jose G.
Published: April 2023

Clinical parameters of subjects from whom plasma was acquired for ELISA analysis.
Figure S3 from BRCA1-Interacting Protein OLA1 Requires Interaction with BARD1 to Regulate Centrosome Number
Authors: Yoshino Yuki , Qi Huicheng , Fujita Hiroki , Shirota Matsuyuki , Abe Shun , Komiyama Yuhei , Shindo Kazuha , Nakayama Masahiro , Matsuzawa Ayako , Kobayashi Akihiro , Ogoh Honami , Watanabe Toshio , Ishioka Chikashi , Chiba Natsuko
Published: April 2023

Direct binding of OLA1 mutants with ï�§-tubulin and the N-terminal region of BRCA1.
Supplementary Figure S2 from FoxO3a Mediates the Inhibitory Effects of the Antiepileptic Drug Lamotrigine on Breast Cancer Growth
Authors: Pellegrino Michele , Rizza Pietro , Nigro Alessandra , Ceraldi Rosangela , Ricci Elena , Perrotta Ida , Aquila Saveria , Lanzino Marilena , Andò Sebastiano , Morelli Catia , Sisci Diego
Published: April 2023

LTG activity depends on PTEN expression.
Supplementary Table III from Therapeutic Targeting of CD146/MCAM Reduces Bone Metastasis in Prostate Cancer
Authors: Zoni Eugenio , Astrologo Letizia , Ng Charlotte K.Y. , Piscuoglio Salvatore , Melsen Janine , Grosjean Joël , Klima Irena , Chen Lanpeng , Snaar-Jagalska Ewa B. , Flanagan Kenneth , van der Pluijm Gabri , Kloen Peter , Cecchini Marco G. , Kruithof-de Julio Marianna , Thalmann George N.
Published: April 2023

Genes upregulated in RNASeq.
Supplementary Table I from Therapeutic Targeting of CD146/MCAM Reduces Bone Metastasis in Prostate Cancer
Authors: Zoni Eugenio , Astrologo Letizia , Ng Charlotte K.Y. , Piscuoglio Salvatore , Melsen Janine , Grosjean Joël , Klima Irena , Chen Lanpeng , Snaar-Jagalska Ewa B. , Flanagan Kenneth , van der Pluijm Gabri , Kloen Peter , Cecchini Marco G. , Kruithof-de Julio Marianna , Thalmann George N.
Published: April 2023

Primers used for qPCR.
Supplementary Tables 1-6 from Mutational Landscape of Ovarian Adult Granulosa Cell Tumors from Whole Exome and Targeted TERT Promoter Sequencing
Authors: Alexiadis Maria , Rowley Simone M. , Chu Simon , Leung Dilys T.H. , Stewart Colin J.R. , Amarasinghe Kaushalya C. , Campbell Ian G. , Fuller Peter J.
Published: April 2023

Table S1: Somatic single nucleotide variants, indel and sequence alteration mutations identified across each sample Table S2: Mutated genes identified in samples with matched germline DNA: 1, 18 and 24 Table S3: Microarray analysis by -124C>T TERT promoter mutation status Table S4: Ingenuity Pathway Analysis on genes that differed by TERT promoter mutation status Table S5: Comparison with a series of large scale analyses looking at mutations in genes that overlap with data in this study Table S6: Mutations in genes identified by Zehir, A et al in 11 aGCT samples
table s5 from Molecular Effects of Stromal-Selective Targeting by uPAR-Retargeted Oncolytic Virus in Breast Cancer
Authors: Jing Yuqi , Chavez Valery , Ban Yuguang , Acquavella Nicolas , El-Ashry Doraya , Pronin Alexey , Chen Xi , Merchan Jaime R.
Published: April 2023

Differential expression for human associated genes at day 5
table s4 from Molecular Effects of Stromal-Selective Targeting by uPAR-Retargeted Oncolytic Virus in Breast Cancer
Authors: Jing Yuqi , Chavez Valery , Ban Yuguang , Acquavella Nicolas , El-Ashry Doraya , Pronin Alexey , Chen Xi , Merchan Jaime R.
Published: April 2023

Differential expression for human associated genes at day 2
Supplementary Figure 1 from Aurora Kinase A Promotes AR Degradation via the E3 Ligase CHIP
Authors: Sarkar Sukumar , Brautigan David L. , Larner James M.
Published: April 2023

Aurora A phosphorylates CHIP in vivo.
table s1 from Molecular Effects of Stromal-Selective Targeting by uPAR-Retargeted Oncolytic Virus in Breast Cancer
Authors: Jing Yuqi , Chavez Valery , Ban Yuguang , Acquavella Nicolas , El-Ashry Doraya , Pronin Alexey , Chen Xi , Merchan Jaime R.
Published: April 2023

CBC and Chemistry
Supplemental Figures and Legends from Activation of PPARγ in Myeloid Cells Promotes Progression of Epithelial Lung Tumors through TGFβ1
Authors: Sippel Trisha R. , Johnson Amber M. , Li Howard Y. , Hanson Dwight , Nguyen Teresa T. , Bullock Bonnie L. , Poczobutt Joanna M. , Kwak Jeff W. , Kleczko Emily K. , Weiser-Evans Mary C. , Nemenoff Raphael A.
Published: April 2023

S1: Differentiation state of CMT-luc and LLC-luc cells. S2: Intratumoral myeloid cell populations do not change with PPARγ knockout or activation. S3: TGFβRII knockdown CMT-luc cells are less responsive to TGF-β1 S4: Loss of PPARγ in myeloid cells does not affect LLC-luc tumor progression. S5: LLC cell response to TGF-β1 treatment.
Supplementary Table S2 from Targeting CREB Pathway Suppresses Small Cell Lung Cancer
Authors: Xia Yifeng , Zhan Cheng , Feng Mingxiang , Leblanc Mathias , Ke Eugene , Yeddula Narayana , Verma Inder M.
Published: April 2023

Supplementary Table S2. PCR primer sets used in the study.
Figure S1 from Loss of Fas Expression and Function Is Coupled with Colon Cancer Resistance to Immune Checkpoint Inhibitor Immunotherapy
Authors: Xiao Wei , Ibrahim Mohammed L. , Redd Priscilla S. , Klement John D. , Lu Chunwan , Yang Dafeng , Savage Natasha M. , Liu Kebin
Published: April 2023

Figure S1. Sensitivity of colon carcinoma cell lines to FasL-induced apoptosis in vitro.
Supplementary Table from Interferon-Stimulated Genes Are Transcriptionally Repressed by PR in Breast Cancer
Authors: Walter Katherine R. , Goodman Merit L. , Singhal Hari , Hall Jade A. , Li Tianbao , Holloran Sean M. , Trinca Gloria M. , Gibson Katelin A. , Jin Victor X. , Greene Geoffrey L. , Hagan Christy R.
Published: April 2023

Supplementary Table 1. Primer and si/shRNA sequences.
Supplementary Figure 3 from Epigenetic Suppression of SERPINB1 Promotes Inflammation-Mediated Prostate Cancer Progression
Authors: Lerman Irina , Ma Xiaoting , Seger Christina , Maolake Aerken , Garcia-Hernandez Maria de la Luz , Rangel-Moreno Javier , Ackerman Jessica , Nastiuk Kent L. , Susiarjo Martha , Hammes Stephen R.
Published: April 2023

Supplementary Figure 3. Epigenetic repression of endogenous NE inhibitors in LNCaP cells.
Supplementary Figure 2 from Epigenetic Suppression of SERPINB1 Promotes Inflammation-Mediated Prostate Cancer Progression
Authors: Lerman Irina , Ma Xiaoting , Seger Christina , Maolake Aerken , Garcia-Hernandez Maria de la Luz , Rangel-Moreno Javier , Ackerman Jessica , Nastiuk Kent L. , Susiarjo Martha , Hammes Stephen R.
Published: April 2023

Supplementary Figure 2. EGF does not induce SERPINB1 expression in prostate cancer cells.
Figure S3 from Establishment and Genetic Landscape of Precancer Cell Model Systems from the Head and Neck Mucosal Lining
Authors: de Boer D. Vicky , Brink Arjen , Buijze Marijke , Stigter-van Walsum Marijke , Hunter Keith D. , Ylstra Bauke , Bloemena Elisabeth , Leemans C. René , Brakenhoff Ruud H.
Published: April 2023

CN profiles of the cultures of patient HN472 revealed multiple fields, not related to the tumor. (A) CN profile of culture HN472-M1 showed two focal aberrations, a loss at chromosome 7p and an gain at chromosome 18p. In addition, a loss at chromosome 18p was detected. (B) The CN profile of culture HN472-M4 had different CNAs, namely two focal losses at 9p (CDKN2A) and 12q, and a more extensive loss at chromosome 6q. (C) The CN profile of the tumor culture generated of this patient displayed numerous CNAs, however none related to the ones found in the precancer samples. For instance, the deletion at chromosome 9p was not at the location of CDKN2A¸but at the location of another HNSCC-annotated gene; PTPRD (Leemans et al. 2011).
Supplementary Text from A Minimal DNA Methylation Signature in Oral Tongue Squamous Cell Carcinoma Links Altered Methylation with Tumor Attributes
Authors: Krishnan Neeraja M. , Dhas Kunal , Nair Jayalakshmi , Palve Vinayak , Bagwan Jamir , Siddappa Gangotri , Suresh Amritha , Kekatpure Vikram D. , Kuriakose Moni Abraham , Panda Binay
Published: April 2023

All the supplementary text
Supplementary Table 4 from A Minimal DNA Methylation Signature in Oral Tongue Squamous Cell Carcinoma Links Altered Methylation with Tumor Attributes
Authors: Krishnan Neeraja M. , Dhas Kunal , Nair Jayalakshmi , Palve Vinayak , Bagwan Jamir , Siddappa Gangotri , Suresh Amritha , Kekatpure Vikram D. , Kuriakose Moni Abraham , Panda Binay
Published: April 2023

Multi-tiered data represented in Circos plot
Supplemental Data from Exosomes from HNSCC Promote Angiogenesis through Reprogramming of Endothelial Cells
Authors: Ludwig Nils , Yerneni Saigopalakrishna S. , Razzo Beatrice M. , Whiteside Theresa L.
Published: April 2023

Figure S1. Characterization of TEX. Figure S2. HUVEC viability expressed in % in response to treatment with exosome uptake inhibitors in increasing concentrations as indicated. Movie S1. Confirmation of internalized exosomes using confocal microscopy. Table S1. Clinicopathological characteristics of the HNSCC patients included in this study.
Supplementary Table 1 from Targeting TAZ-Driven Human Breast Cancer by Inhibiting a SKP2-p27 Signaling Axis
Authors: Shen He , Yang Nuo , Truskinovsky Alexander , Chen Yanmin , Mussell Ashley L. , Nowak Norma J. , Kobzik Lester , Frangou Costa , Zhang Jianmin
Published: April 2023

Differential expression genes following 24 hrs Dox removals.
Supplementary Spreadsheet S4 from p53 Maintains Baseline Expression of Multiple Tumor Suppressor Genes
Authors: Pappas Kyrie , Xu Jia , Zairis Sakellarios , Resnick-Silverman Lois , Abate Francesco , Steinbach Nicole , Ozturk Sait , Saal Lao H. , Su Tao , Cheung Pamela , Schmidt Hank , Aaronson Stuart , Hibshoosh Hanina , Manfredi James , Rabadan Raul , Parsons Ramon
Published: April 2023

List of genes deleted at a frequency of 0.5% or greater in all cancer types in TCGA (used in GSEA). Acronyms for cancer types are expanded in the Materials and Methods.
Supplemental materials and methods from Targeting TAZ-Driven Human Breast Cancer by Inhibiting a SKP2-p27 Signaling Axis
Authors: Shen He , Yang Nuo , Truskinovsky Alexander , Chen Yanmin , Mussell Ashley L. , Nowak Norma J. , Kobzik Lester , Frangou Costa , Zhang Jianmin
Published: April 2023

Supplemental materials and methods
Supplementary Tables from A Transcriptional Program for Detecting TGFβ-Induced EMT in Cancer
Authors: Foroutan Momeneh , Cursons Joseph , Hediyeh-Zadeh Soroor , Thompson Erik W. , Davis Melissa J.
Published: April 2023

Expanded and additional tables supporting this manuscript.
Supplementary Data, Figures and Table from HDAC1 Is a Required Cofactor of CBFβ-SMMHC and a Potential Therapeutic Target in Inversion 16 Acute Myeloid Leukemia
Authors: Richter Lisa E. , Wang Yiqian , Becker Michelle E. , Coburn Rachel A. , Williams Jacob T. , Amador Catalina , Hyde R. Katherine
Published: April 2023

Supplemental Figure 1. HDAC2 binding to CBFÎ²-SMMHC is not detected in transfected COS-7 cells. Supplemental Figure 2. CBFB-MYH11N63K, N104K, Î"179-221 mutant eliminates RUNX1 binding. Supplemental Figure 3. CBFB does not Co-IP with HDAC1. Supplemental Figure 4. HDAC1 knockdown induces myeloid differentiation. Supplemental Figure 5. Vorinostat recapitulates effects of entinostat on CM+ colony formation and differentiation. Supplemental Figure 6. Entinostat treatment has diverse effect on gene expression. Supplemental Figure 7. HDAC3 inhibition is not the cause of the sensitivity of CM+ cells to entinostat treatment. Supplemental Figure 8. Entinostat does not affect normal blood cells. Supplemental Table 1. List of antibodies, manufacturer, and catalog number used for western blot
Supplemental Figure Legends from Radiation-Induced Myofibroblasts Promote Tumor Growth via Mitochondrial ROS–Activated TGFβ Signaling
Authors: Shimura Tsutomu , Sasatani Megumi , Kawai Hidehiko , Kamiya Kenji , Kobayashi Junya , Komatsu Kenshi , Kunugita Naoki
Published: April 2023

S1. The percentage of TIG-3 and MRC-5 cells with alpha-SMA staining exposed to indicated doses is shown in the graph. S2. Tumor volumes of HeLa, HeLa+MRC-5 0FR tumors, HeLa+MRC-5 0.05FR tumors, HeLa+MRC-5 NAC 0FR tumors, and HeLa+MRC-5 0.05FR tumors.
FIgure S2 from Radiation-Induced Myofibroblasts Promote Tumor Growth via Mitochondrial ROS–Activated TGFβ Signaling
Authors: Shimura Tsutomu , Sasatani Megumi , Kawai Hidehiko , Kamiya Kenji , Kobayashi Junya , Komatsu Kenshi , Kunugita Naoki
Published: April 2023

Individual tumor measurements data
Figure S3 from IKKβ-Mediated Resistance to Skin Cancer Development Is Ink4a/Arf-Dependent
Authors: Page Angustias , Bravo Ana , Suarez-Cabrera Cristian , Alameda Josefa P. , Casanova M. Llanos , Lorz Corina , Segrelles Carmen , Segovia José C. , Paramio Jesús M. , Navarro Manuel , Ramirez Angel
Published: April 2023

Expression of IKKbeta, K13 and Phospho-AKT in papillomas and carcinomas of p53EKO and p53EKO/K5-IKKbeta mice.
Figure S6 from De Novo Fatty Acid Synthesis-Driven Sphingolipid Metabolism Promotes Metastatic Potential of Colorectal Cancer
Authors: Jafari Naser , Drury James , Morris Andrew J. , Onono Fredrick O. , Stevens Payton D. , Gao Tianyan , Liu Jinpeng , Wang Chi , Lee Eun Y. , Weiss Heidi L. , Evers B. Mark , Zaytseva Yekaterina Y.
Published: April 2023

Supplemental Figure 6. Inhibition of sphingolipid metabolism by FTY-720 reduces tumor weight in patient-derived xenograft tumors.
Supplementary Figure S6 from Potent EMT and CSC Phenotypes Are Induced By Oncostatin-M in Pancreatic Cancer
Authors: Smigiel Jacob M. , Parameswaran Neetha , Jackson Mark W.
Published: April 2023

OSM promotes migration on multiple matrices
Supplementary Figure S5 from Potent EMT and CSC Phenotypes Are Induced By Oncostatin-M in Pancreatic Cancer
Authors: Smigiel Jacob M. , Parameswaran Neetha , Jackson Mark W.
Published: April 2023

Endogenous OSM expression and recombinant OSM does not alter cell growth
Figure S4 from De Novo Fatty Acid Synthesis-Driven Sphingolipid Metabolism Promotes Metastatic Potential of Colorectal Cancer
Authors: Jafari Naser , Drury James , Morris Andrew J. , Onono Fredrick O. , Stevens Payton D. , Gao Tianyan , Liu Jinpeng , Wang Chi , Lee Eun Y. , Weiss Heidi L. , Evers B. Mark , Zaytseva Yekaterina Y.
Published: April 2023

Supplemental Figure 4. Inhibition of FASN and sphingolipid metabolism inhibits migration in primary CRC cells.
Supplementary Figure S2 from Potent EMT and CSC Phenotypes Are Induced By Oncostatin-M in Pancreatic Cancer
Authors: Smigiel Jacob M. , Parameswaran Neetha , Jackson Mark W.
Published: April 2023

Schematic of FACS to isolate CD24HI/CD44LOW and CD24LOW/CD44HI cells from parental HPAC
Supplementary Data 4 from Abemaciclib Is Effective Against Pancreatic Cancer Cells and Synergizes with HuR and YAP1 Inhibition
Authors: Dhir Teena , Schultz Christopher W. , Jain Aditi , Brown Samantha Z. , Haber Alex , Goetz Austin , Xi Chunhua , Su Gloria H. , Xu Liang , Posey James , Jiang Wei , Yeo Charles J. , Golan Talia , Pishvaian Michael J. , Brody Jonathan R.
Published: April 2023

Supplemental figure 4: (A) Mia PaCa2 xenograft tumor volume plotted over time for mice that had no treatment or abemaciclib treatment daily for 9 days. (B) Graphical representation of tumor volume (left) in no treatment and abemaciclib treated mice with n=5, two tumors per mice. All mice, including one outlier mouse in the abemaciclib arm, shown for comparison to Figure 5. Graphical representation of tumor weights after sacrifice are shown, including one outlier mouse in the abemaciclib arm, shown for comparison to Figure 5 (right). (C) Xenograft tumors from all experimental arms were collected at day 69 at the end of the experiment and harvested for western blot analysis, and probed for pRb, ser 780. Quantification of the western blot is shown above the blot.
Table S11 from Genetic and Epigenetic Determinants of Aggressiveness in Cribriform Carcinoma of the Prostate
Authors: Elfandy Habiba , Armenia Joshua , Pederzoli Filippo , Pullman Eli , Pertega-Gomes Nelma , Schultz Nikolaus , Viswanathan Kartik , Vosoughi Aram , Blattner Mirjam , Stopsack Konrad H. , Zadra Giorgia , Penney Kathryn L. , Mosquera Juan Miguel , Tyekucheva Svitlana , Mucci Lorelei A. , Barbieri Christopher , Loda Massimo
Published: April 2023

Function and aberration of differentially methylated genes between Cribriform and noncribriform.
Table S1, S2, S3 from Genetic and Epigenetic Determinants of Aggressiveness in Cribriform Carcinoma of the Prostate
Authors: Elfandy Habiba , Armenia Joshua , Pederzoli Filippo , Pullman Eli , Pertega-Gomes Nelma , Schultz Nikolaus , Viswanathan Kartik , Vosoughi Aram , Blattner Mirjam , Stopsack Konrad H. , Zadra Giorgia , Penney Kathryn L. , Mosquera Juan Miguel , Tyekucheva Svitlana , Mucci Lorelei A. , Barbieri Christopher , Loda Massimo
Published: April 2023

Table S1: IDs of Cribriform (ICC) & Non-cribriform (NC4) TCGA cases; Table S2: Comparison between cribriform and non-cribriform based on TCGA clusters; Table S3: Somatic Copy Number Variation (SCNV) enriched in Cribriform Carcinoma (ICC) compared to Noncribriform (NC4), corrected for Fraction Genome Altered (FGA) and Gleason Score (GS).
Supplementary Figures S1-S6 from Genetic and Epigenetic Determinants of Aggressiveness in Cribriform Carcinoma of the Prostate
Authors: Elfandy Habiba , Armenia Joshua , Pederzoli Filippo , Pullman Eli , Pertega-Gomes Nelma , Schultz Nikolaus , Viswanathan Kartik , Vosoughi Aram , Blattner Mirjam , Stopsack Konrad H. , Zadra Giorgia , Penney Kathryn L. , Mosquera Juan Miguel , Tyekucheva Svitlana , Mucci Lorelei A. , Barbieri Christopher , Loda Massimo
Published: April 2023

Supplemental figure 1: Examples of cribriform and noncribriform carcinoma; Supplemental figure 2: Scheme of Sample Selection; Supplemental figure 3: Examples of PTEN Immunostaining of Tissue Microarray (TMA) Cores, HPFS/ PHS Prostate Cancer Cohorts; Supplementary figure 4: Invasive Cribriform Carcinoma is Associated with High Gleason Score and Tumor Stage (TCGA datasets); Supplementary figure 5. Difference in FGA between Cribriform Carcinoma (ICC) and Noncribriform Carcinoma (NC4) as well as between Gleason scores (in TCGA dataset); Supplementary figure 6: Cribriform Morphology in PTENloss and SPOPmut Transgenic Mouse Prostate Model.
Supplementary Table 2 from Distinct Afatinib Resistance Mechanisms Identified in Lung Adenocarcinoma Harboring an EGFR Mutation
Authors: Yamaoka Toshimitsu , Ohmori Tohru , Ohba Motoi , Arata Satoru , Murata Yasunori , Kusumoto Sojiro , Ando Koichi , Ishida Hiroo , Ohnishi Tsukasa , Sasaki Yasutsuna
Published: April 2023

Mutational analysis of EGFR in PC-9, AFR1, AFR2, and AFR3 cells.
Supplementary Figure 4 from Distinct Afatinib Resistance Mechanisms Identified in Lung Adenocarcinoma Harboring an EGFR Mutation
Authors: Yamaoka Toshimitsu , Ohmori Tohru , Ohba Motoi , Arata Satoru , Murata Yasunori , Kusumoto Sojiro , Ando Koichi , Ishida Hiroo , Ohnishi Tsukasa , Sasaki Yasutsuna
Published: April 2023

Epithelial-to-mesenchymal transition (EMT) induction was not observed in afatinib-resistant clones.
Figure S1 from Genetic and Epigenetic Determinants of Aggressiveness in Cribriform Carcinoma of the Prostate
Authors: Elfandy Habiba , Armenia Joshua , Pederzoli Filippo , Pullman Eli , Pertega-Gomes Nelma , Schultz Nikolaus , Viswanathan Kartik , Vosoughi Aram , Blattner Mirjam , Stopsack Konrad H. , Zadra Giorgia , Penney Kathryn L. , Mosquera Juan Miguel , Tyekucheva Svitlana , Mucci Lorelei A. , Barbieri Christopher , Loda Massimo
Published: April 2023

(A) Cribriform carcinoma, (B) Noncribriform carcinoma.
Supplementary Figure 2 from Distinct Afatinib Resistance Mechanisms Identified in Lung Adenocarcinoma Harboring an EGFR Mutation
Authors: Yamaoka Toshimitsu , Ohmori Tohru , Ohba Motoi , Arata Satoru , Murata Yasunori , Kusumoto Sojiro , Ando Koichi , Ishida Hiroo , Ohnishi Tsukasa , Sasaki Yasutsuna
Published: April 2023

Decrease in enhanced KRAS expression to levels comparable with that of parental PC-9 cells following a 2-month drug holiday in AFR1 cells.
Supplementary Table S2 from Comprehensive Transcriptome and Mutational Profiling of Endemic Burkitt Lymphoma Reveals EBV Type–Specific Differences
Authors: Kaymaz Yasin , Oduor Cliff I. , Yu Hongbo , Otieno Juliana A. , Ong'echa John Michael , Moormann Ann M. , Bailey Jeffrey A.
Published: April 2023

Significantly differentially expressed genes results after incorporating the surrogate variable analysis.
Supplementary Table S4 from Down-Regulation of hsa-miR-10a in Chronic Myeloid Leukemia CD34+ Cells Increases USF2-Mediated Cell Growth
Authors: Agirre Xabier , Jiménez-Velasco Antonio , San José-Enériz Edurne , Garate Leire , Bandrés Eva , Cordeu Lucia , Aparicio Oscar , Saez Borja , Navarro Germán , Vilas-Zornoza Amaia , Pérez-Roger Ignacio , García-Foncillas Jesús , Torres Antonio , Heiniger Anabel , Calasanz María José , Fortes Puri , Román-Gómez José , Prósper Felipe
Published: April 2023

Supplementary Table S4 from Down-Regulation of hsa-miR-10a in Chronic Myeloid Leukemia CD34+ Cells Increases USF2-Mediated Cell Growth
Supplementary Table S2 from Down-Regulation of hsa-miR-10a in Chronic Myeloid Leukemia CD34+ Cells Increases USF2-Mediated Cell Growth
Authors: Agirre Xabier , Jiménez-Velasco Antonio , San José-Enériz Edurne , Garate Leire , Bandrés Eva , Cordeu Lucia , Aparicio Oscar , Saez Borja , Navarro Germán , Vilas-Zornoza Amaia , Pérez-Roger Ignacio , García-Foncillas Jesús , Torres Antonio , Heiniger Anabel , Calasanz María José , Fortes Puri , Román-Gómez José , Prósper Felipe
Published: April 2023

Supplementary Table S2 from Down-Regulation of hsa-miR-10a in Chronic Myeloid Leukemia CD34+ Cells Increases USF2-Mediated Cell Growth
Supplementary Figures S1-S6 from Down-Regulation of hsa-miR-10a in Chronic Myeloid Leukemia CD34+ Cells Increases USF2-Mediated Cell Growth
Authors: Agirre Xabier , Jiménez-Velasco Antonio , San José-Enériz Edurne , Garate Leire , Bandrés Eva , Cordeu Lucia , Aparicio Oscar , Saez Borja , Navarro Germán , Vilas-Zornoza Amaia , Pérez-Roger Ignacio , García-Foncillas Jesús , Torres Antonio , Heiniger Anabel , Calasanz María José , Fortes Puri , Román-Gómez José , Prósper Felipe
Published: April 2023

Supplementary Figures S1-S6 from Down-Regulation of hsa-miR-10a in Chronic Myeloid Leukemia CD34+ Cells Increases USF2-Mediated Cell Growth
Supplementary Table 1 from Expression of Wnt3 Activates Wnt/β-Catenin Pathway and Promotes EMT-like Phenotype in Trastuzumab-Resistant HER2-Overexpressing Breast Cancer Cells
Authors: Wu Yanyuan , Ginther Charles , Kim Juri , Mosher Nicole , Chung Seyung , Slamon Dennis , Vadgama Jaydutt V.
Published: April 2023

PDF file - 67K, Primers sequences used for the studies
Supplemental Figure 6 from DNA-Directed Polymerase Subunits Play a Vital Role in Human Telomeric Overhang Processing
Authors: Diotti Raffaella , Kalan Sampada , Matveyenko Anastasiya , Loayza Diego
Published: April 2023

Supplemental Figure 6. A. Western blot for HeLaII transfected with the siRNAs indicated on top. The analysis was performed 48 hours post-transfection. B. Telomeric overhang analysis in HelaII depleted for 180 with the indicated siRNAs, using the DSN (double strandspecific nuclease) technique. Briefly, four micrograms of genomic DNA were digested with 0.8 U of double strand-specific nuclease (DSN) as per manufacturer instructions, ran on a 6% PAGE, transferred to a membrane, and hybridized to a C-rich (CCCTAA) probe. Undigested and ExoI controls were ran alongside, as labeled below the gel. See materials and methods, and (32) for further details. C. Quantitation of the overhangs detected in panel B, with values from three independent experiments. The two-tailed Student t test for the two significant values (<0.05) are shown.
Supplementary Figure 3 from The ATPase Activity of Reptin Is Required for Its Effects on Tumor Cell Growth and Viability in Hepatocellular Carcinoma
Authors: Grigoletto Aude , Neaud Véronique , Allain-Courtois Nathalie , Lestienne Patrick , Rosenbaum Jean
Published: April 2023

PDF file - 48K, Cell cycle analysis by propidium iodide staining.
Supplementary Figure 2 from The ATPase Activity of Reptin Is Required for Its Effects on Tumor Cell Growth and Viability in Hepatocellular Carcinoma
Authors: Grigoletto Aude , Neaud Véronique , Allain-Courtois Nathalie , Lestienne Patrick , Rosenbaum Jean
Published: April 2023

PDF file - 199K, Effect of D299N mutant expression and endogenous Reptin replacement on Hep3B cells growth.
Supplementary Figures 1 - 4 from Significance of PELP1 in ER-Negative Breast Cancer Metastasis
Authors: Roy Sudipa , Chakravarty Dimple , Cortez Valerie , De Mukhopadhyay Keya , Bandyopadhyay Abhik , Ahn Jung-Mo , Raj Ganesh V. , Tekmal Rajeshwar R. , Sun LuZhe , Vadlamudi Ratna K.
Published: April 2023

PDF file - 648KB
Supplementary Table 2 from RhoC Is an Unexpected Target of RhoGDI2 in Prevention of Lung Colonization of Bladder Cancer
Authors: Griner Erin M. , Dancik Garrett M. , Costello James C. , Owens Charles , Guin Sunny , Edwards Michael G. , Brautigan David L. , Theodorescu Dan
Published: April 2023

Supplementary Table 2. Differential expression of RhoC/RhoGDI2 signature genes
Supplementary Figure 5 from The ATM Substrate KAP1 Controls DNA Repair in Heterochromatin: Regulation by HP1 Proteins and Serine 473/824 Phosphorylation
Authors: White David , Rafalska-Metcalf Ilona U. , Ivanov Alexey V. , Corsinotti Andrea , Peng Hongzhuang , Lee Sheng-Chung , Trono Didier , Janicki Susan M. , Rauscher Frank J.
Published: April 2023

PDF file - 206K
Supplementary Figure 4 from The ATM Substrate KAP1 Controls DNA Repair in Heterochromatin: Regulation by HP1 Proteins and Serine 473/824 Phosphorylation
Authors: White David , Rafalska-Metcalf Ilona U. , Ivanov Alexey V. , Corsinotti Andrea , Peng Hongzhuang , Lee Sheng-Chung , Trono Didier , Janicki Susan M. , Rauscher Frank J.
Published: April 2023

PDF file - 112K
Supplementary Figure 2 from The ATM Substrate KAP1 Controls DNA Repair in Heterochromatin: Regulation by HP1 Proteins and Serine 473/824 Phosphorylation
Authors: White David , Rafalska-Metcalf Ilona U. , Ivanov Alexey V. , Corsinotti Andrea , Peng Hongzhuang , Lee Sheng-Chung , Trono Didier , Janicki Susan M. , Rauscher Frank J.
Published: April 2023

PDF file - 235K
Supplementary Figure 1 from Acquisition of the Metastatic Phenotype Is Accompanied by H2O2-Dependent Activation of the p130Cas Signaling Complex
Authors: Hempel Nadine , Bartling Toni R. , Mian Badar , Melendez J. Andres
Published: April 2023

PDF file - 34K, Catalase (CAT, 500U/ml) and N-acetylcysteine (NAC, 2mM) do not significantly inhibit 253J cell migration in a wound healing assay. Cells were pre-treated for 18 hours in complete media. Wound healing was carried out in 0% serum media containing the same antioxidant concentrations for 24 hrs (n=5).
Supplementary Figure S1 from Neural Stem Cell Tropism to Glioma: Critical Role of Tumor Hypoxia
Authors: Zhao Donghong , Najbauer Joseph , Garcia Elizabeth , Metz Marianne Z. , Gutova Margarita , Glackin Carlotta A. , Kim Seung U. , Aboody Karen S.
Published: April 2023

Supplementary Figure S1 from Neural Stem Cell Tropism to Glioma: Critical Role of Tumor Hypoxia
Supplementary Table 1 from Yes-Associated Protein 1 Is Activated and Functions as an Oncogene in Meningiomas
Authors: Baia Gilson S. , Caballero Otavia L. , Orr Brent A. , Lal Anita , Ho Janelle S. Y. , Cowdrey Cynthia , Tihan Tarik , Mawrin Christian , Riggins Gregory J.
Published: April 2023

XLS file - 13K, Summary of nuclear YAP1 immunohistochemistry in human meningiomas
Supplementary Figure 4 from Yes-Associated Protein 1 Is Activated and Functions as an Oncogene in Meningiomas
Authors: Baia Gilson S. , Caballero Otavia L. , Orr Brent A. , Lal Anita , Ho Janelle S. Y. , Cowdrey Cynthia , Tihan Tarik , Mawrin Christian , Riggins Gregory J.
Published: April 2023

PDF file - 114K, YAP1 overexpression promotes in vitro cell proliferation of meningioma cells
Supplementary Figure 2 from Yes-Associated Protein 1 Is Activated and Functions as an Oncogene in Meningiomas
Authors: Baia Gilson S. , Caballero Otavia L. , Orr Brent A. , Lal Anita , Ho Janelle S. Y. , Cowdrey Cynthia , Tihan Tarik , Mawrin Christian , Riggins Gregory J.
Published: April 2023

PDF file - 99K, Knockdown of YAP1 by siRNA transfection decreases YAP1 mRNA levels in SF1335 meningioma cells